Readystate Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$756K Buy
31,400
+400
+1% +$10.5K 0.03% 484
2026
Q1
$870K Buy
+31,000
New +$825K 0.04% 259
2025
Q2
Sell
-75,700
Closed -$1.92M 866
2025
Q1
$1.92M Sell
75,700
-16,600
-18% -$434K 0.06% 328
2024
Q4
$2.45M Sell
92,300
-407,000
-82% -$11M 0.08% 268
2024
Q3
$14.4M Buy
499,300
+475,500
+1,998% +$13.9M 0.27% 125
2024
Q2
$666K Sell
23,800
-614,600
-96% -$16.9M 0.02% 433
2024
Q1
$17.7M Buy
638,400
+632,100
+10,033% +$17.5M 0.25% 64
2023
Q4
$181K Buy
+6,300
New +$190K 0.01% 537
2023
Q2
Sell
-7,600
Closed -$310K 388
2023
Q1
$310K Buy
+7,600
New +$328K 0.03% 244

Other funds holding PFE

Readystate Asset Management's PFE Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 9,927 shares worth $239K. The stake represents 0.01% of the portfolio and ranks #800 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in PFE as recently as Q4 2024.

Readystate Asset Management first reported a position in PFE in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.04M in Q4 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Readystate Asset Management held 9,927 shares of Pfizer worth $239K as of Q2 2026.
  • Pfizer was a new Readystate Asset Management position in Q2 2026.
  • Pfizer made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #800 holding.
  • Readystate Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 2 quarters since.
  • Readystate Asset Management's Pfizer position peaked at $1.04M in Q4 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.